- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2013
- Public Summary Document (PSD) November 2013 PBAC Meeting - PDF
Infliximab – November 2013
Infliximab, powder for intravenous infusion, 100mg, Remicade®
Last updated
8 November 2023